Molecular Partners Ag
Clinical trials sponsored by Molecular Partners Ag, explained in plain language.
-
New drug MP0533 tested in leukemia patients – could it control the disease?
Disease control Recruiting nowThis study is testing a new drug, MP0533, in about 249 adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has come back or not responded to treatment. The goal is to find the safest dose and see if the drug can help control the cancer. Participants wi…
Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New radiation therapy targets tough lung cancers in early trial
Disease control Recruiting nowThis study tests a new drug that delivers radiation directly to cancer cells with a protein called DLL3, found in small cell lung cancer and similar tumors. About 138 adults with advanced cancer that has not responded to standard treatments will receive the drug to check safety, …
Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated May 18, 2026 12:11 UTC